Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.455 USD | -3.36% | -1.09% | -68.84% |
06/05 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
06/05 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-68.84% | 1.5Cr | |
-1.62% | 8.92TCr | |
+1.32% | 4.05TCr | |
-15.73% | 3.28TCr | |
+64.13% | 2.62TCr | |
-21.28% | 1.45TCr | |
-8.50% | 1.31TCr | |
-44.07% | 1.16TCr | |
-13.06% | 1.15TCr | |
+4.94% | 881.83Cr |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- Sector Update: Health Care